GUAIFENESIN - ODAAT
- Product NDC
- 83139-175
- 11-digit product format
- 831390175
- Labeler code
- 83139
- Product ID
- 83139-175_f61d3ae0-11ec-2a82-e053-2995a90a95da
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- LODAAT LLC
- Application
- ANDA213420
- Marketing category
- ANDA
- Marketing start
- 2023-03-04
- Substance
- GUAIFENESIN
- Active strength
- 1200 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GUAIFENESIN - ODAAT
- Brand name suffix
- 1200 MG
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 1200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ |
| Rxcui | 310621 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 83139-175-01 | GUAIFENESIN - ODAAT1200 MG | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 83139-175 | GUAIFENESIN - ODAAT 1200 MG (GUAIFENESIN) TABLET [LODAAT LLC] | 1 | Current NDC, 1 package rows | 20230307_f61d3ae0-11eb-2a82-e053-2995a90a95da.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 83139-175-01 | 83139017501 | 100 TABLET in 1 BOTTLE (83139-175-01) | 100 tablet | 2023-03-04 | No | No | Current |